clinical trial · NCT04987762
Safety and Tolerability Study of Adhansia XR® Extended-Release Capsules in Children
Attention Deficit/Hyperactivity DisorderAdhansia XR
brief summary
The purpose of this study is to assess the long-term safety of Adhansia XR in children and to characterize the pharmacokinetics (PK) in 4 to 5 year-olds.
started
Aug 3, 2021
primary completion
Apr 27, 2022
completion
Apr 27, 2022
last updated
Aug 22, 2023
official title
An Open-Label, Multicenter, Multiple-Dose, Safety and Tolerability Study of Adhansia XR® Extended-Release Capsules in Children 4 to 12 Years of Age
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol